Formulation Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
| |
Unit Size 100 µg | |
Storage Instructions Aliquot and store at -20°C. Minimize freezing and thawing. | |
Synonym / Alias Names malignant transformation suppression 1|S100 calcium-binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog)|S100 calcium-binding protein A4|S100 calcium binding protein A4 (calcium protein, calvasculin, metastasin, murine placental homolog)|PEL98|P9KA|MTS1|42A|18A2|S100 calcium binding protein A4|CAPL|S100A4 | |
Accession ID NP_002952.1; NP_062427.1 | |
Blocking Peptide EBP07493 | |
Immunogen Peptide with sequence CNEFFEGFPDKQP, from the C Terminus of the protein sequence according to NP_002952.1; NP_062427.1. | |
Product Comments Both variants (NP_002952.1; NP_062427.1) represent identical protein. | |
Peptide Sequence CNEFFEGFPDKQP | |
Purification Method Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. | |
Shipping Instructions Refrigerated | |
Predicted Species Human, Mouse, Rat, Dog | |
Reactive Species Human | |
Human Gene ID 6275 | |
Mouse Gene ID 20198 | |
Rat Gene ID 24615 | |
Product Grade  | |
IHC Results In paraffin embedded Human Small Intestine shows staining of lymphatic cells in the lamina propria. Recommended concentration: 1-2µg/ml. | |
ELISA Detection Limit Antibody detection limit dilution 1:128000. | |
Western Blot Approx 13kDa band observed in Human Peripheral blood mononuclear cells lysates (calculated MW of 11.7kDa according to NP_002952.1). Recommended concentration: 0.05-0.2µg/ml. Primary incubation was 1 hour. | |
Application Type Pep-ELISA, WB, IHC |
Goat Anti-S100A4 / CAPL Antibody
$423.00
| SKU | Unit Size | Price |
|---|---|---|
Select a unit size:
Selected References [{"pmid": 24037664, "intro": "This antibody (previous batch) has been successfully used in Western blot on Human:", "title": "Comparative secretome analysis of epithelial and mesenchymal subpopulations of head and neck squamous cell carcinoma identifies S100A4 as a potential therapeutic target.", "author": "Rasanen K, Sriswasdi S, Valiga A, Tang HY, Zhang G, Perego M, Somasundaram R, Li L, Speicher K, Klein-Szanto AJ, Basu D, Rustgi AK, Speicher DW, Herlyn M.", "journal": "Mol Cell Proteomics. 2013 Dec;12(12):3778-92."}] |